Qilu.com· Lightning News News On June 26, 2022, the "Digital Therapy and Diabetes Management Summit Forum" was held in Jinan, Shandong. This forum was hosted by Shandong Industrial Technology Research Institute , a subsidiary of Silicon Bionics Co-organized by Shandong Silicon Computing Technology Co., Ltd., well-known experts and scholars from across the country in diabetes, information technology, artificial intelligence and other fields and cross-professionals gathered together. The theme of the
forum is "Digital Therapy and Diabetes Management". Focusing on new technologies, from the perspectives of evidence-based medicine, clinical application and future development, we jointly explore the feasibility of digital therapy for diabetes management, and use digital bureaus to directly or indirectly detect, prevent and Slowing down the progression of the disease has extremely important social value and clinical significance for disease treatment and health management.
Diabetes digital therapy has become a future development trend
The prevalence of diabetes has been rising, with an increase of 56% in the past ten years. The management cycle of diabetes is long, and related health care expenditures are as high as ¥1,052.6 billion, which has become a huge public health burden.
As a supplement to traditional treatment methods, digital therapy is essentially the digitization of medical services. It uses big data technology to collect, track and evaluate clinical outcome data based on evidence-based medicine, and has good health economics benefits.
Professor Chen Li from Qilu Hospital of Shandong University pointed out that since the COVID-19 epidemic, the number of domestic Internet diagnosis and treatment users and the frequency of use have increased rapidly, and digital chronic disease management has ushered in unprecedented popularity. Among them, patients with metabolic diseases represented by diabetes are considered to be the most suitable group for digital medical management. Effective "cloud intervention" for patients with chronic diseases through digital medical tools can delay the progression of the patient's disease and may even reverse it.
Domestic “artificial pancreas” can be expected in the future
“Artificial pancreas” is one of the most popular topics among diabetic patients. The ideal artificial pancreas closed-loop system should be able to automatically calculate the insulin dosage and appropriate infusion time required by the patient through an algorithm based on real-time monitoring of changes in the patient's glucose levels, and use an insulin pump for infusion, thus Achieve good blood sugar control. The role of future closed-loop algorithms and continuous glucose monitoring devices is particularly critical.
Professor Hou Xinguo from Qilu Hospital of Shandong University said " With the rise of a number of outstanding domestic companies represented by silicon-based computing power, the independently developed continuous glucose monitoring technology has reached the international advanced level, and we will continue to develop products with independent intellectual property rights. It is only a matter of time before the insulin fully closed-loop algorithm can fill the domestic gap and catch up with the international level. ”
Overall, the State Food and Drug Administration has not yet approved any insulin fully closed-loop algorithm. Therefore, it is necessary to develop independent knowledge. The fully closed-loop insulin algorithm of property rights has high social value for filling domestic gaps and promoting industrial development.
Shi Xianbao, general manager of Shandong Silicon Computing Technology Co., Ltd., said: "Currently, the company is actively promoting the integration and application of CGM and insulin algorithms and striving to complete the technological breakthrough of domestic artificial pancreas, with a view to providing professional blood sugar for hundreds of millions of Chinese diabetic patients. Management services. "
's silicon-based computing power relies on leading medical artificial intelligence technology and complete innovative medical device industrialization capabilities, and has been deeply involved in the field of chronic disease management. In November 2021, the continuous glucose monitoring system became my country's first calibration-free real-time CGM product approved for marketing, showing high safety and effectiveness in clinical applications. Silicon-based computing power will be implemented around the insulin closed-loop algorithm, and the functions of the insulin closed-loop algorithm will be realized based on the blood glucose data of the continuous glucose monitoring system, the patient's carbohydrate, protein and fat intake, and the patient's insulin sensitivity coefficient. , providing research data for the realization and localization of my country's artificial pancreas closed-loop system.
Clinical value of digital therapy for diabetes
About digital therapy for diabetes.Shandong Provincial HospitalDean Zhao Jiajun said: The key to clinical medicine is translational medicine. The application of scientific research and technology must be clinically oriented and ultimately applied to medical practice to achieve breakthroughs in technology and methods and form New technologies, new treatments and new guidelines will promote the improvement of clinical diagnosis and treatment. The application of the new intelligent blood glucose monitoring system allows us to see the possibility of standard management rates for diabetes patients. Its application marks a solid step in the exploration of digital therapy in the field of diabetes management. In the future, in the closed loop of monitoring + treatment, The application of artificial intelligence, big data, and algorithms will become a revolution in digital therapy for diabetes.
Dean of Qilu Hospital of Shandong University Chen Yuguo believes that the theme of "Digital Therapy and Diabetes Management Summit Forum" is in line with the current concepts and requirements of a healthy China and life first. With the rapid development of new technologies such as the Internet, big data and cloud computing , digital has entered health and patients, profoundly affecting medical work. Digital health, digital health and digital therapy have been recognized by experts in the health field. How to use big data and scientific algorithms to solve certain problems in the health field has become a topic of common concern among industry experts and related industries, among which diabetes is a good direction.
Director Guan Qingbo of the Department of Endocrinology and Metabolism of Shandong Provincial Hospital also pointed out that currently too many diabetic patients do not have perfect monitoring and supervision, resulting in substandard blood sugar management. However, through an intelligent and digital monitoring system, doctors and patients can Even family members can control the patient's blood sugar status in real time anytime and anywhere, and provide timely intervention and guidance on the patient's diet and exercise, which greatly improves the patient's compliance with sugar control. With the continuous advancement of insulin digital therapy, diabetes management has changed from manual management to intelligent management, which can greatly improve management efficiency. "We hope that outstanding digital therapy companies represented by silicon-based computing power can realize the industrialization of artificial pancreas closed-loop systems as soon as possible, so that patients with diabetes can receive better medical services."
Silicon-based bionics promotes the development of the diabetes digital therapy industry
Silicon-based Bionic has established "Shandong Silicon Computing Technology Co., Ltd." as the main promotion base for promoting the insulin closed-loop algorithm. Regarding the implementation of silicon-based computing power in Shandong Industrial Technology Research Institute, Sun Dianyi, president of Shandong Industrial Technology Research Institute, said that he will actively promote excellent digital therapy companies like silicon-based computing power to establish partnerships with medical experts, scientific research institutions and industrial platforms. relationship, and strive to create a high-quality incubation platform for the global digital therapy industry and a highland for China's digital therapy industry.
